WRBY
Warby Parker Inc. · NYSE · Healthcare · USD · 10-K for 2025, filed 2026-02-26
Figures on this page computed 2026-11-08 12:40 UTC
Last close
21.29USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-02-26
2548.0xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001504776-26-000006
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-26
-0.9%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001504776-26-000006
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
0.2%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001504776-26-000006
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
5.0%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001504776-26-000006
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
0.63Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001504776-26-000006
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Price is the furthest below its sector's middle: 0.11 against 0.36 on the market's range.
- Growth17.2%79 of 100, above its sector
- Returns on capital-0.9%37 of 100, above its sector
- Margins54.0%53 of 100, above its sector
- Price2548.0x11 of 100, below its sector
- Safety0.6363 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Against its rival
lens 4 of 9Measure by measure
behind on 2 of 6- Profit on each unit of sales0.2%0.0%Ahead
Higher is better here.
- Return on the capital it uses-0.9%0.6%Behind
Higher is better here.
- Sales growth over five years17.2%11.9%Ahead
Higher is better here.
- Debt against equity0.630.63Behind
Lower is better here.
- Gross margin54.0%36.8%Ahead
Higher is better here.
- Price against earnings2,548x5,737xAhead
Lower is better here.
The first column is this company and the second is the one it is set against. A measure only one of the two reports is left at n/a rather than counted as a win.
Against ICU Medical, Inc., WRBY is behind on 2 of 6 measures.
Against ICU Medical, Inc., WRBY is behind on 2 of 6 measures.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-02-26
Profit on each unit of sales0.2%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001504776-26-000006
- Reported in
- USD
Return on the capital it uses-0.9%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001504776-26-000006
- Reported in
- USD
Sales growth over five years17.2%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001504776-26-000006
- Reported in
- USD
Debt against equity0.63
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001504776-26-000006
- Reported in
- USD
Gross margin54.0%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001504776-26-000006
- Reported in
- USD
Price against earnings2548.0x
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001504776-26-000006
- Reported in
- USD